Literature DB >> 31853530

Uranium(iv) cyclobutadienyl sandwich compounds: synthesis, structure and chemical bonding.

Nikolaos Tsoureas1, Akseli Mansikkamäki2, Richard A Layfield1.   

Abstract

The 1 : 1 reactions of uranium(iv) tetrakis(borohydride) with the sodium and potassium salts of the cyclobutadienyl anion [C4(SiMe3)4]2- (Cb'''') produce the half-sandwich complexes [Na(12-crown-4)2][U(η4-Cb'''')(BH4)3] and [U(η4-Cb'''')(μ-BH4)3{K(THF)2}]2. In the 1 : 2 reaction of U(BH4)4 with Na2Cb'''', formation of [U(η4-Cb'''')(η3-C4H(SiMe3)3-κ-(CH2SiMe2)(BH4))]- reveals that a Cb'''' ligand undergoes an intramolecular deprotonation, resulting in an allyl/tuck-in bonding mode. A computational study reveals that the uranium-Cb'''' bonding has an appreciable covalent component with contributions from the uranium 5f and 6d orbitals.

Entities:  

Year:  2019        PMID: 31853530     DOI: 10.1039/c9cc09018e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

Review 1.  Uranium: The Nuclear Fuel Cycle and Beyond.

Authors:  Bárbara Maria Teixeira Costa Peluzo; Elfi Kraka
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

2.  An Allyl Uranium(IV) Sandwich Complex: Are ϕ Bonding Interactions Possible?

Authors:  Ivan A Popov; Brennan S Billow; Stephanie H Carpenter; Enrique R Batista; James M Boncella; Aaron M Tondreau; Ping Yang
Journal:  Chemistry       Date:  2022-04-01       Impact factor: 5.020

3.  Heteroleptic actinocenes: a thorium(iv)-cyclobutadienyl-cyclooctatetraenyl-di-potassium-cyclooctatetraenyl complex.

Authors:  Josef T Boronski; Ashley J Wooles; Stephen T Liddle
Journal:  Chem Sci       Date:  2020-06-10       Impact factor: 9.825

4.  Dominance of Cyclobutadienyl Over Cyclopentadienyl in the Crystal Field Splitting in Dysprosium Single-Molecule Magnets.

Authors:  James P Durrant; Benjamin M Day; Jinkui Tang; Akseli Mansikkamäki; Richard A Layfield
Journal:  Angew Chem Int Ed Engl       Date:  2022-02-26       Impact factor: 16.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.